Published in Int J Cancer on May 15, 1979
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet (1991) 4.31
Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92
Allergenic pollen and pollen allergy in Europe. Allergy (2007) 3.58
Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med (1989) 3.33
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol (1992) 2.91
Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood (1997) 2.75
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol (2000) 2.71
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy (2008) 2.18
Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology (2000) 2.04
FREQUENCY OF INFECTION IN DONOR EYES POST MORTEM: A METHOD OF OBTAINING STERILE EYES FOR CORNEAL GRAFTING. Br J Ophthalmol (1962) 2.01
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood (1993) 1.94
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol (1998) 1.85
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
Lysozyme turnover in the rat. J Clin Invest (1971) 1.78
Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc (1994) 1.77
SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med (2001) 1.71
Regional localization of DNA probes on the short arm of chromosome 11 using aniridia-Wilms' tumor-associated deletions. Hum Genet (1987) 1.67
Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood (1995) 1.61
Morningness/eveningness and the need for sleep. J Sleep Res (1999) 1.60
Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniasis in chronically infected BALB/c mice. Eur Cytokine Netw (1998) 1.59
Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies. J Epidemiol Community Health (2008) 1.56
Prospective association between food sensitization and food allergy: results of the LISA birth cohort study. Clin Exp Allergy (2009) 1.55
Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy. Br J Haematol (1993) 1.55
Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life. Allergy (2009) 1.54
How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med (1998) 1.52
Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? Clin Exp Allergy (2011) 1.51
Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy (2008) 1.50
Effects of alfentanil and lidocaine on the hemodynamic responses to laryngoscopy and tracheal intubation. J Clin Anesth (1990) 1.49
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol (1991) 1.49
The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol (1996) 1.45
Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol (1994) 1.44
Predicting side-effects in venom immunotherapy by basophil activation? Allergy (2006) 1.42
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol (1993) 1.42
Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma. Am J Clin Pathol (1990) 1.41
Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood (1998) 1.41
Sleep-disordered breathing and upper-airway anomalies in first-degree relatives of ALTE children. Pediatr Res (2001) 1.40
Adverse events following NPSA guidelines. Anaesthesia (2003) 1.39
A complication of percutaneous tracheostomy whilst using the Combitube for airway control. Eur J Anaesthesiol (1997) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
[Growing pains of cochranology]. Ugeskr Laeger (1999) 1.38
Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology (2000) 1.37
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet (1988) 1.36
Lysozyme turnover in man. J Clin Invest (1972) 1.33
Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology (1997) 1.30
Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol (1983) 1.25
A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy (2010) 1.24
Projections of the effects of climate change on allergic asthma: the contribution of aerobiology. Allergy (2010) 1.23
Why are allergies increasing? Curr Opin Immunol (2001) 1.23
A simplified method of treating burns of the hands. Br J Plast Surg (1971) 1.23
Trends in the incidence of leukemia in Denmark, 1943-77: an epidemiologic study of 14,000 patients. J Natl Cancer Inst (1983) 1.22
Airway diseases and allergies in East and West German children during the first 5 years after reunification: time trends and the impact of sulphur dioxide and total suspended particles. Int J Epidemiol (1999) 1.20
Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther (2011) 1.19
Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet (2004) 1.19
Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Res (1977) 1.16
A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. Eur J Biochem (1992) 1.15
Anaphylactoid reaction to oxytocin in pregnancy. Anaesthesia (1985) 1.13
Phosphorus losses from agricultural areas in river basins: effects and uncertainties of targeted mitigation measures. J Environ Qual (2005) 1.12
Effect of anabolic steroids on rat heart muscle cells. I. Intermediate filaments. Cell Tissue Res (1977) 1.12
Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood (1990) 1.12
Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand (1982) 1.10
CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med (2001) 1.10
Isolation and study of functional mast cells from lung and mesentery of the guinea pig. Agents Actions (1977) 1.10
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood (2000) 1.10
Role of Helicobacter pylori eradication in high-grade MALT lymphoma. Lancet (1995) 1.09
Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol (2000) 1.08
The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (1995) 1.08
Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study. Am J Clin Pathol (1994) 1.07
Influence of short-term exposure to airborne Der p 1 and volatile organic compounds on skin barrier function and dermal blood flow in patients with atopic eczema and healthy individuals. Clin Exp Allergy (2006) 1.07
Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood (1986) 1.06
Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis (1990) 1.05
Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology (1983) 1.05
The effect of environmental tobacco smoke on eczema and allergic sensitization in children. Br J Dermatol (2004) 1.04
Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial. Allergy (2009) 1.04
Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics. Acta Med Scand (1975) 1.04
Muramidase activity of bone marrow plasma. Studies in haematologically normal individuals and in granulocytopenic patients. Acta Med Scand (1969) 1.04
Toxicity and elemental composition of particulate matter from outdoor and indoor air of elementary schools in Munich, Germany. Indoor Air (2011) 1.04
The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood (1992) 1.03
Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry (1998) 1.02
Ultrastructure of isolated human mast cells during histamine release induced by ionophore A 23187. Int Arch Allergy Appl Immunol (1978) 1.02
Receptor binding of lactoferrin by human monocytes. Br J Haematol (1983) 1.02
The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol (1998) 1.01
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters. Am J Clin Oncol (2001) 1.01
Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol (1994) 1.01
The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol (2009) 1.01
Ensemble modelling of nutrient loads and nutrient load partitioning in 17 European catchments. J Environ Monit (2009) 1.01
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol (1989) 1.01
Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy (2005) 1.01
Ragweed sensitization in Europe - GA(2)LEN study suggests increasing prevalence. Allergy (2009) 0.99
Chronic neutrophil leukaemia in adolescence and young adulthood. Br J Haematol (1996) 0.99
Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy. Allergy (2006) 0.99
Hypercalcaemia in the accelerated phase of chronic myelogenous leukaemia: no relationship to the phenotype of the blast cells. Scand J Haematol (1985) 0.99